Marathon Petroleum Corporation
—- Market cap
- —
- Debt
- +$33.31B
- Cash
- −$3.67B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: MPC stock price vs XOM: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at XOM's multiple
Needs XOM P/E.
Implied fair value · at MPC's multiple
Needs MPC P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Marathon Petroleum Corporation · implied price per share
Bear
$176.29
Base
$213.72
Bull
$274.68
Exxon Mobil Corporation · implied price per share
A valid share-count denominator is required for the selected valuation policy.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe MPC can materially improve margins and reduce leverage toward XOM levels (narrowing the net margin gap to ~8% and cutting Net Debt/EBITDA well below 3.7x), then buy MPC because the stock trades ~30.6% below a P/E-implied price of $292.52 and at cheaper P/E, P/S and EV/EBITDA multiples versus XOM; otherwise hold due to leverage and margin risks.
MPC's P/E-based implied price of $292.52 implies a 30.6% upside from the current $223.93, driven by MPC trading at lower multiples than XOM (P/E, P/S, EV/EBITDA). XOM-implied valuation range is extremely wide, and MPC's current price sits well within its historical band, signalling potential for re-rating but also sizable model sensitivity.
Supporting Metrics